At a glance
ClinicalIndex Comparison RecordN/ACompleted· 168 enrolled
Drug / intervention
Copper-based surfaces plus copper-enriched linenother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Copper Use as Protection Against Antimicrobial Resistance in the ICU
In Brief
A clinical study evaluating Copper-based surfaces plus copper-enriched linen for Healthcare Associated Infection. Completed, enrolled 168 participants across 1 site.
Detailed Summary
CUPRIC is an investigator initiated and conducted, prospective, quasi-experimental study to determine whether the combined use of copper-alloyed objects plus copper-enriched textiles reduce the burden of MDRO colonization and HAIs incidence in the critically ill population.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthcare Associated Infection
CountriesChile
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartNov 2020
First PostedMay 2021
Primary CompletionDec 2021
Study CompletionDec 2022
TodayJul 2026
First PostedMay 5, 2021
Enrollment StartNov 2, 2020
Primary CompletionDec 31, 2021
Study CompletionDec 31, 2022
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 5.2 years ago
Interventions
Copper-based surfaces plus copper-enriched linenother
We will assess the efficacy of our intervention to decrease the acquisition of nasal and intestinal colonization with MDROs and the development of HAIs in the ICU setting.